Epitope Spreading in Immune-Mediated Glomerulonephritis: The Expanding Target.
Humans
Glomerulonephritis
/ immunology
Epitopes
/ immunology
Glomerulonephritis, Membranous
/ immunology
Animals
Lupus Nephritis
/ immunology
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
/ immunology
Autoantibodies
/ immunology
Receptors, Phospholipase A2
/ immunology
Autoimmune Diseases
/ immunology
autoimmune glomerulonephritis
epitope spreading
epitope-specific immune response
glomerular disease progression
targeted immunotherapy
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
16 Oct 2024
16 Oct 2024
Historique:
received:
28
09
2024
revised:
04
10
2024
accepted:
14
10
2024
medline:
26
10
2024
pubmed:
26
10
2024
entrez:
26
10
2024
Statut:
epublish
Résumé
Epitope spreading is a critical mechanism driving the progression of autoimmune glomerulonephritis. This phenomenon, where immune responses broaden from a single epitope to encompass additional targets, contributes to the complexity and severity of diseases such as membranous nephropathy (MN), lupus nephritis (LN), and ANCA-associated vasculitis (AAV). In MN, intramolecular spreading within the phospholipase A2 receptor correlates with a worse prognosis, while LN exemplifies both intra- and intermolecular spreading, exacerbating renal involvement. Similarly, ANCA reactivity in AAV highlights the destructive potential of epitope diversification. Understanding these immunological cascades reveals therapeutic opportunities-targeting early epitope spreading could curb disease progression. Despite promising insights, the clinical utility of epitope spreading as a prognostic tool remains debated. This review provides a complete overview of the current evidence, exploring the dual-edged nature of epitope spreading, the intricate immune mechanisms behind it, and its therapeutic implications. By elucidating these dynamics, we aim to pave the way for more precise, targeted interventions in autoimmune glomerular diseases.
Identifiants
pubmed: 39456878
pii: ijms252011096
doi: 10.3390/ijms252011096
pii:
doi:
Substances chimiques
Epitopes
0
Autoantibodies
0
Receptors, Phospholipase A2
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM